News Briefs: CMS Revamps Reporting Standards

CMS on July 6 released new reporting requirements for states regarding Medicaid and CHIP. The new reporting requirements include updated network adequacy and access standards, a standard format for medical loss ratio reporting, and updates to a web portal for reporting submissions and, eventually, rolled-up data and dashboards compiled from regulatory filings. “The tools we’re releasing today reflect the latest — and certainly not the last — step CMS is taking to increase transparency and ensure that people served through Medicaid and CHIP managed care programs are receiving high-quality, high-value care,” said CMS Administrator Chiquita Brooks-LaSure in a press release.

The FDA will allow pharmacists to prescribe Pfizer Inc.’s Paxlovid. Patients may be prescribed Paxlovid from a state-licensed pharmacist if they test positive for COVID-19 and provide “electronic or printed health records less than 12 months old, including the most recent reports of laboratory blood work for the state-licensed pharmacist to review for kidney or liver problems,” and “a list of all medications they are taking, including over-the-counter medications so the state-licensed pharmacist can screen for drugs with potentially serious interactions with Paxlovid,” per an FDA press release. The federal government purchased a large amount of Paxlovid doses and has distributed them to pharmacies and clinics across the country — though the drug is not being used as widely as experts predicted.

0 Comments
© 2022 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

a-hospital-building
December 2

Cross-Market Hospital Systems Flex Negotiating Power, to Payers’ Detriment

READ MORE
businessman-putting-cash-in-pocket
December 2

Health Insurance Startup CEOs’ Sky-High Compensation Figures Are Deceiving

Read More
businessman-viewing-news-update-journalism-headline-on-a-laptop
December 2

News Briefs: Growing Share of Large Firms Choose Medicare Advantage for Retiree Health Benefits

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today